Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease

Journal of Hepatology

Volumn 40, Issue 6, 2004, Pages 897-903

  Said, Adnan ^a   Williams, John ^a   Holden, Jeremy ^a   Remington, Patrick ^a   Gangnon, Ronald ^a   Musat, Alexandru ^a   Lucey, Michael R ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Child Turcotte Pugh score; Cirrhosis; CTP, Child Turcotte Pugh; ESLD, end stage liver disease; Hepatic encephalopathy; MELD, model for end stage liver disease; Outcomes; Receiver operating characteristic curves; ROC, receiver operating characteristic

Indexed keywords

ADULT; AGED; ALCOHOL LIVER DISEASE; ARTICLE; CHRONIC LIVER DISEASE; CONTROLLED STUDY; FEMALE; HAZARD ASSESSMENT; HEPATIC ENCEPHALOPATHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MODEL; MODEL FOR END STAGE LIVER DISEASE SCORE; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; ROC CURVE; SCORING SYSTEM; SURVIVAL;

FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER DISEASES; LIVER FAILURE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 1642537949     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(04)00064-9     Document Type: Article

References (29)

1. Kamath P.S., Wiesner R.H., Malinchoc M., Kremers W., Therneau T.M., Kosberg C.L., et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 33:2001;464-470
2. Wiesner R.H., McDiarmid S.V., Kamath P.S., Edwards E.B., Malinchoc M., Kremers W.K., et al. MELD and PELD application of survival models to liver allocation. Liver Transpl. 7:2001;567-580
3. Sheth M., Riggs M., Patel T. Utility of the Mayo End-Stage Liver Disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis. BMC Gastroenterol. 2:2002;2
4. Chalasani N., Kahi C., Francois F., Pinto A., Marathe A., Bini E.J., et al. Model for end-stage liver disease (MELD) for predicting mortality in patients with acute variceal bleeding. Hepatology. 35:2002;1282-1284
5. Wiesner R., Edwards E., Freeman R., Harper A., Kim R., Kamath P., et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology. 124:2003;91-96
6. Schiff E.R., Sorrell M.F., Maddrey W.C. Schiff E.R., Sorrell M.F., Maddrey W.C. Schiff's diseases of the liver. 8th ed. 1999;Lippincott-Raven, Philadelphia, New York
7. Grant B.F., Dufour M.C., Harford T.C. Epidemiology of alcoholic liver disease. Semin Liver Dis. 8:1988;12-25
8. Gitlin N. Hepatic encephalopathy. Zakim D.B.T. 3rd ed. Hepatology: a textbook of liver disease. vol. 1:1996;605-617 WB Saunders, Philadelphia
9. Ederer F.A.L., Cutler S.J. The relative survival rate: a statistical methodology. End results and mortality trends in cancer. 1961;US Govt. Print Office, Baltimore, MD, Washington, DC. p. 101-121
10. Christensen E., Neuberger J., Crowe J., Altman D.G., Popper H., Portmann B., et al. Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial. Gastroenterology. 89:1985;1084-1091
11. Therneau T.M., Grambsch P.M. Modeling survival data: extending the Cox model. 2000;Springer, New York
12. Peto R., Pike M.C., Armitage P., Breslow N.E., Cox D.R., Howard S.V., et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer. 35:1977;1-39
13. Hanley J.A., McNeil B.J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 143:1982;29-36
14. Hanley J.A., McNeil B.J. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 148:1983;839-843
15. McNeil B.J., Hanley J.A. Statistical approaches to the analysis of receiver operating characteristic (ROC) curves. Med Decis Making. 4:1984;137-150
16. Dorfman D.D., Alf E. Jr. Maximum likelihood estimation of parameters of signal detection theory - a direct solution. Psychometrika. 33:1968;117-124
17. Carithers R.L. Jr, Herlong H.F., Diehl A.M., Shaw E.W., Combes B., Fallon H.J., et al. Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial. Ann Intern Med. 110:1989;685-690
18. Akriviadis E., Botla R., Briggs W., Han S., Reynolds T., Shakil O. Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. Gastroenterology. 119:2000;1637-1648
19. Botta F., Giannini E., Romagnoli P., Fasoli A., Malfatti F., Chiarbonello B., et al. MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study. Gut. 52:2003;134-139
20. Angermayr B., Cejna M., Karnel F., Gschwantler M., Koenig F., Pidlich J., et al. Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt. Gut. 52:2003;879-885
21. Schepke M., Roth F., Fimmers R., Brensing K.A., Sudhop T., Schild H.H., et al. Comparison of MELD. Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting. Am J Gastroenterol. 98:2003;1167-1174
22. Salerno F., Merli M., Cazzaniga M., Valeriano V., Rossi P., Lovaria A., et al. MELD score is better than Child-Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt. J Hepatol. 36:2002;494-500
23. del Olmo J.A., Pena A., Serra M.A., Wassel A.H., Benages A., Rodrigo J.M. Predictors of morbidity and mortality after the first episode of upper gastrointestinal bleeding in liver cirrhosis. J Hepatol. 32:2000;19-24
24. Cooper G.S., Bellamy P., Dawson N.V., Desbiens N., Fulkerson W.J. Jr, Goldman L., et al. A prognostic model for patients with end-stage liver disease. Gastroenterology. 113:1997;1278-1288
25. Yoo H.Y., Edwin D., Thuluvath P.J. Relationship of the model for end-stage liver disease (MELD) scale to hepatic encephalopathy, as defined by electroencephalography and neuropsychometric testing, and ascites. Am J Gastroenterol. 98:2003;1395-1399
26. Powell W.J. Jr., Klatskin G. Duration of survival in patients with Laennec's cirrhosis. Influence of alcohol withdrawal, and possible effects of recent changes in general management of the disease. Am J Med. 44:1968;406-420
27. Pessione F., Ramond M.J., Njapoum C., Duchatelle V., Degott C., Erlinger S., et al. Cigarette smoking and hepatic lesions in patients with chronic hepatitis C. Hepatology. 34:2001;121-125
28. Mori M., Hara M., Wada I., Hara T., Yamamoto K., Honda M., et al. Prospective study of hepatitis B and C viral infections, cigarette smoking, alcohol consumption, and other factors associated with hepatocellular carcinoma risk in Japan. Am J Epidemiol. 151:2000;131-139
29. Forman L.M., Lucey M.R. Predicting the prognosis of chronic liver disease: an evolution from child to MELD. Mayo end-stage liver disease. Hepatology. 33:2001;473-475